Abstract: The present invention includes an antimicrobial peptide consisting of, consisting essentially of, or comprising, at least one of SEQ ID NO:1-20, nucleic acids encoding the peptides, methods for using the antimicrobial peptide generating plants which express the peptides sufficient to endow the plants with resistance to pathogenic bacteria and fungi, the use of the nucleic acids to produce peptides by cellular production such as fermentation or plant production systems of the antimicrobial peptide(s), and the use of the isolated antimicrobial peptide(s) in a spray or other mixture to treat plants to protect them from disease.

Abstract: Aspergillus flavus is an opportunistic, saprophytic fungus that infects maize and other fatty acid-rich food and feed crops and produces toxic and carcinogenic secondary metabolites known as aflatoxins. In vitro studies showed a five-fold increase in antifungal activity of AGM182 (vs. tachyplesin1) against A. flavus. Transgenic maize plants expressing AGM182 under maize Ubiquitin-1 promoter were produced through Agrobacterium-mediated transformation. PCR products confirmed integration of the AGM182 gene, while RT-PCR of maize RNA confirmed the presence of AGM182 transcripts. Maize kernel screening assay using a highly aflatoxigenic A. flavus strain (AF70) showed up to 72% reduction in fungal growth in the transgenic AGM182 seeds compared to isogenic negative control seeds.

Abstract: This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity.

Abstract: This invention relates to novel lytic peptides which are effective in treating citrus plant diseases including canker and greening. The invention also relates to antimicrobial compositions comprising lytic peptides and the use of such compositions in methods for treating diseases of citrus plants.

Abstract: This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity.

Abstract: This invention relates to novel lytic peptides which are effective in treating citrus plant diseases including canker and greening. The invention also relates to antimicrobial compositions comprising lytic peptides and the use of such compositions in methods for treating diseases of citrus plants.

Abstract: This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity.